Sunday, January 19, 2025

CATEGORY

MHRA

NICE Recommends Alectinib to Prevent ALK-Positive Lung Cancer Recurrence

In a significant breakthrough for lung cancer treatment, the National Institute for Health and Care Excellence (NICE) has endorsed alectinib, known commercially as Alecensa,...

NICE Challenges Donanemab’s Value for Alzheimer’s Treatment in NHS

The National Institute for Health and Care Excellence (NICE) has stirred discussion in the medical community by questioning the value of donanemab, a new...

Vabysmo Shows Promising Results for Underrepresented Groups in DME Treatment

A recent groundbreaking study has highlighted significant advancements in treating diabetic macular edema (DME) for African American, Black, Hispanic, and Latino populations. Conducted by...

UK Launches Pioneering mRNA Norovirus Vaccine Trial

The UK is on the brink of a significant breakthrough in public health, as the first Phase 3 clinical trial for an mRNA norovirus...

Advancements in AI Technology Reshape Industries Worldwide

Artificial intelligence (AI) continues to redefine traditional business landscapes, integrating itself into various sectors with remarkable speed. Its applications stretch beyond tech companies, offering...

MHRA Approves Elafibranor as First Treatment for Primary Biliary Cholangitis

Key TakeawaysElafibranor (Iqirvo) is now approved by the MHRA to treat adults with primary biliary cholangitis (PBC), a rare chronic liver disease. The...

MHRA Urges Immediate Reporting of Safety Concerns with Glucose Monitors and Insulin Pumps

Key TakeawaysThe MHRA is asking patients to report any safety issues with continuous glucose monitors (CGMs) or insulin pumps through the Yellow Card...

MHRA Approves First-Ever Treatment for Rare Immune Disorder APDS Through Fast-Track Process

Key TakeawaysThe MHRA has approved leniolisib phosphate (Joenja) for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS), a rare immune disorder. This...

ABPI Preparing for the Windsor Framework: Ensuring Smooth UK Medicines Supply Beyond 2025

Key TakeawaysThe Windsor Framework, fully effective from January 2025, introduces a two-category system for UK medicines, increasing regulatory complexity between the UK and...

Defining Purpose and Use in Medical Device Regulation: A Critical Perspective

In the fast-paced world of medical device regulation, clear definitions of intended purpose and indications for use are paramount. These elements not only influence...

COVID-19 Vaccine Targeting JN.1 Variant Receives MHRA Approval, Expanding Access Through NHS and Private Purchase

Key TakeawaysModerna’s updated Spikevax® JN.1 COVID-19 vaccine has received MHRA approval in the UK, targeting the JN.1 Omicron subvariant to protect high-risk individuals...

Aspivix’s Carevix Device Receives MHRA Approval, Expanding Gynecological Care in the UK

Key Takeaways:The Carevix device by Aspivix has received approval from the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK, marking a...

Medicines Procurement from Abroad: Türkiye Updates Guidelines to Ensure Continuity of Care and Patient Access

Key TakeawaysThe TÄ°TCK has released an updated "Guideline on the Procurement of Medicines from Abroad," streamlining the process for importing essential pharmaceuticals that...

Alzheimer’s Treatment Leqembi® (Lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain

Alzheimer’s disease (AD) has taken another significant step forward in treatment, with the authorization of Leqembi® (lecanemab) in Great Britain for the treatment of...

Predictive Health Intelligence Expands Liver Disease Screening with MHRA Clearance for hepatoSIGHTâ„¢

Predictive Health Intelligence's groundbreaking product, hepatoSIGHTâ„¢, has received Class I medical device clearance from the Medicines and Healthcare products Regulatory Agency (MHRA), marking a...

Latest news